Georgia's Online Cancer Information Center

Find A Clinical Trial

A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in Participants With Advanced Gastric Cancer (FRACTION-Gastric Cancer)

Status
Active
Cancer Type
Stomach/ Gastric Cancer
Trial Phase
Phase II
Eligibility
18 - 110 Years, Male and Female
Study Type
Treatment
NCD ID
NCT02935634
Protocol IDs
CA018-003 (primary)
NCI-2017-00025
2016-002807-24
Study Sponsor
Bristol-Myers Squibb

Summary

The purpose of this study is to determine whether Nivolumab in combination with other therapies is more effective than Nivolumab in combination with Ipilimumab in treating patients / subjects with advanced gastric cancer.
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.